Royalty Pharma (RPRX) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free RPRX Stock Alerts $28.41 -0.35 (-1.22%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Royalty Pharma Short Interest DataCurrent Short Volume14,150,000 sharesPrevious Short Volume12,390,000 sharesChange Vs. Previous Month+14.21%Dollar Volume Sold Short$399.74 millionShort Interest Ratio / Days to Cover5.2Last Record DateApril 15, 2024Outstanding Shares597,430,000 sharesFloat Size378,530,000 sharesShort Percent of Float3.74%Today's Trading Volume2,041,654 sharesAverage Trading Volume2,899,539 sharesToday's Volume Vs. Average70% Short Selling Royalty Pharma ? Sign up to receive the latest short interest report for Royalty Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRPRX Short Interest Over TimeRPRX Days to Cover Over TimeRPRX Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Royalty Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202414,150,000 shares $399.74 million +14.2%3.7%5.2 $28.25 3/31/202412,390,000 shares $376.28 million -2.1%3.3%4.7 $30.37 3/15/202412,650,000 shares $380.64 million -3.7%3.3%4.9 $30.09 2/29/202413,130,000 shares $398.36 million +14.2%3.5%4.8 $30.34 2/15/202411,500,000 shares $345.35 million +11.9%3.0%4.1 $30.03 1/31/202410,280,000 shares $291.85 million +0.9%2.7%4.1 $28.39 Get the Latest News and Ratings for RPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Royalty Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/202410,190,000 shares $289.19 million -9.1%2.7%4.3 $28.38 12/31/202311,210,000 shares $314.89 million -9.2%2.9%4.8 $28.09 12/15/202312,340,000 shares $337.75 million +23.3%3.2%5.3 $27.37 11/30/202310,010,000 shares $270.97 million +1.8%2.6%4.3 $27.07 11/15/20239,830,000 shares $265.61 million -10.4%2.6%4.5 $27.02 10/31/202310,970,000 shares $294.76 million -2.8%2.9%5 $26.87 10/15/202311,290,000 shares $314.31 million +8.0%3.0%5.2 $27.84 9/30/202310,450,000 shares $283.61 million +11.7%2.8%4.8 $27.14 9/15/20239,360,000 shares $263.30 million +9.5%2.5%4.3 $28.13 8/31/20238,550,000 shares $254.96 million -8.7%2.3%3.7 $29.82 8/15/20239,360,000 shares $278.93 million +0.2%2.5%3.9 $29.80 7/31/20239,340,000 shares $293.09 million -14.2%2.5%3.9 $31.38 7/15/202310,890,000 shares $334.65 million +23.2%2.9%4.6 $30.73 6/30/20238,840,000 shares $271.74 million +1.1%2.4%3.9 $30.74 6/15/20238,740,000 shares $281.43 million +15.3%2.3%4 $32.20 5/31/20237,580,000 shares $248.17 million +5.6%2.0%3.7 $32.74 5/15/20237,180,000 shares $246.49 million -7.4%1.9%3.7 $34.33 4/30/20237,750,000 shares $272.41 million +1.7%2.1%4.1 $35.15 4/15/20237,620,000 shares $276.30 million +0.9%2.1%4.1 $36.26 3/31/20237,550,000 shares $272.03 million -1.2%2.0%4 $36.03 3/15/20237,640,000 shares $263.58 million +3.7%2.1%4.2 $34.50 2/28/20237,370,000 shares $264.21 million +7.1%2.0%4.5 $35.85 2/15/20236,880,000 shares $259.31 million +8.2%1.9%4.4 $37.69 1/31/20236,360,000 shares $249.25 million -10.4%1.7%4.2 $39.19 1/15/20237,100,000 shares $279.53 million -9.0%1.9%4.8 $39.37 12/30/20227,800,000 shares $308.26 million +4.4%2.1%5.3 $39.52 12/15/20227,470,000 shares $304.70 million -2.9%2.0%4.9 $40.79 11/30/20227,690,000 shares $338.13 million +35.6%2.1%4.7 $43.97 11/15/20225,670,000 shares $238.59 million -14.7%1.6%3.4 $42.08 10/31/20226,650,000 shares $281.43 million -22.1%1.8%4.1 $42.32 10/15/20228,540,000 shares $353.64 million -0.5%2.4%5 $41.41 9/30/20228,580,000 shares $344.74 million -5.3%2.4%4.6 $40.18 9/15/20229,060,000 shares $382.06 million -9.9%2.5%4.6 $42.17 8/31/202210,050,000 shares $420.19 million -17.3%2.8%5.2 $41.81Urgent Nvidia Warning (Ad)Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… RPRX Short Interest - Frequently Asked Questions What is Royalty Pharma's current short interest? Short interest is the volume of Royalty Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 14,150,000 shares of RPRX short. 3.74% of Royalty Pharma's shares are currently sold short. Learn More on Royalty Pharma's current short interest. What is a good short interest ratio for Royalty Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPRX shares currently have a short interest ratio of 5.0. Learn More on Royalty Pharma's short interest ratio. Which institutional investors are shorting Royalty Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Royalty Pharma: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Royalty Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.74% of Royalty Pharma's floating shares are currently sold short. Is Royalty Pharma's short interest increasing or decreasing? Royalty Pharma saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 14,150,000 shares, an increase of 14.2% from the previous total of 12,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Royalty Pharma's float size? Royalty Pharma currently has issued a total of 597,430,000 shares. Some of Royalty Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Royalty Pharma currently has a public float of 378,530,000 shares. How does Royalty Pharma's short interest compare to its competitors? 3.74% of Royalty Pharma's shares are currently sold short. Here is how the short interest of companies compare to Royalty Pharma: Corebridge Financial, Inc. (10.27%), Loews Co. (1.05%), Aegon Ltd. (0.15%), AerCap Holdings (1.04%), Northern Trust Co. (0.86%), The Carlyle Group Inc. (7.77%), Nomura Holdings, Inc. (0.05%), Shinhan Financial Group Co., Ltd. (0.14%), Essex Property Trust, Inc. (2.38%), Brookfield Asset Management Ltd. (4.64%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Royalty Pharma stock? Short selling RPRX is an investing strategy that aims to generate trading profit from Royalty Pharma as its price is falling. RPRX shares are trading down $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Royalty Pharma? A short squeeze for Royalty Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RPRX, which in turn drives the price of the stock up even further. How often is Royalty Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPRX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRBG Short Interest L Short Interest AEG Short Interest AER Short Interest NTRS Short Interest CG Short Interest NMR Short Interest SHG Short Interest ESS Short Interest BAM Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry